Product Information
MESALAMINE ER 0.375 GRAM CAP is a generic product labeled by American Health Packaging, priced at $0.4979 per EA under NDC 60687065032. Its NADAC has been published 194 times since Oct 12, 2022.
Strength
.375 g/1
Manufacturer
American Health PackagingNDC
60687065032
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214242On Market Since
9/6/2022
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE ER 0.375 GRAM CAP has been published 194 times since Oct 12, 2022, and over the history we have for it it has declined 55.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4979 per EA |
|---|---|
| All-time high | $1.1495 (Dec 14, 2022) |
| All-time low | $0.4196 (Feb 18, 2026) |
| 52-week high | $0.4979 |
| 52-week low | $0.4196 |
| Median price | $0.5473 |
| Average price | $0.6468 |
| Largest weekly change | -38.7% (Jul 17, 2024) |
| Weeks tracked | 194 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE ER 0.375 GRAM CAP?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 0.375 GRAM CAP, manufactured by American Health Packaging, is $0.4979 per EA (NDC 60687065032), effective Jun 24, 2026.
How has the price of MESALAMINE ER 0.375 GRAM CAP changed over time?
Over the history we have for it, the NADAC for MESALAMINE ER 0.375 GRAM CAP has declined 55.6%. It has been tracked across 194 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for MESALAMINE ER 0.375 GRAM CAP?
Since Oct 12, 2022, the NADAC for MESALAMINE ER 0.375 GRAM CAP has ranged from a low of $0.4196 (Feb 18, 2026) to a high of $1.1495 (Dec 14, 2022), with a median of $0.5473 per EA.
Are there cheaper alternatives to MESALAMINE ER 0.375 GRAM CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE ER 0.375 GRAM CAP, but none are currently priced below it.
Who manufactures MESALAMINE ER 0.375 GRAM CAP?
MESALAMINE ER 0.375 GRAM CAP (NDC 60687065032) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification